Latest information on COVID-19

Professor of Medicine and of Microbiology & Immunology Stanford University

Jeffrey Glenn, M.D., Ph.D. is a Professor of Medicine (Division of Gastroenterology & Hepatology) and Microbiology & Immunology at Stanford University School of Medicine, and the Director of the Center for Hepatitis and Liver Tissue Engineering.

Antiviral Program for Pandemics

The Antiviral Program for Pandemics (APP) aims to develop safe and effective antivirals to combat SARS-CoV-2, the virus that causes COVID-19, as well as to build sustainable platforms for targeted drug discovery and development of a robust pipeline of antivirals against viruses with pandemic potential.

Interferon Shot Might Keep COVID-19 Patients Out of the Hospital

 

An experimental antiviral drug known as peginterferon lambda can speed up COVID-19 patients' ability to shed the virus and recover, scientists report.